PI3K/Akt in IPF: untangling fibrosis and charting therapies
Idiopathic Pulmonary Fibrosis (IPF) is a chronic, progressive lung disease characterized by abnormal epithelial repair, persistent inflammation, and excessive extracellular matrix deposition, leading to irreversible scarring and respiratory failure. Central to its pathogenesis is the dysregulation o...
Saved in:
| Main Authors: | Janki Bhatt, Alessandra Ghigo, Emilio Hirsch |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-03-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1549277/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cyanidin-3-glucoside upregulated NDRG2 through the PI3K/AKT pathway to alleviate EMT and ECM in renal fibrosis
by: Qianxue Lu, et al.
Published: (2025-03-01) -
Mechanism of DNASE1L3 delaying renal fibrosis by inhibiting PI3K-AKT signaling pathway
by: WEI Xiao, et al.
Published: (2025-05-01) -
Screening of active components in Astragalus mongholicus Bunge and Panax notoginseng formula for anti-fibrosis in CKD: nobiletin inhibits Lgals1/PI3K/AKT signaling to improve renal fibrosis
by: Fang Yang, et al.
Published: (2024-12-01) -
Aloe-emodin ameliorates chronic kidney disease fibrosis by inhibiting PI3K-mediated signaling pathway
by: Ming Chen, et al.
Published: (2025-08-01) -
Non-lethal sonodynamic therapy mitigates hypertensive renal fibrosis through the PI3K/AKT/mTORC1-autophagy pathway
by: DanDan Liu, et al.
Published: (2025-02-01)